A new immunotherapy approach could work for many types of cancer
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
Search Stories
Fraternities and sororities at MIT raise funds for local charities
“Our students’ ... dedication reflects not only their generosity, but also the spirit of engaging the MIT community in giving back through philanthropy.”
Startup’s tablets deliver cancer drugs more evenly over time
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
Inflammation jolts “sleeping” cancer cells awake, enabling them to multiply again
Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.
“Bottlebrush” particles deliver big chemotherapy payloads directly to cancer cells
Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.
Four from MIT named 2025 Goldwater Scholars
Rising seniors Avani Ahuja, Julianna Lian, Jacqueline Prawira, and Alex Tang are honored for their academic achievements.
Faces of MIT: Michele David
The chief of clinical quality and patient safety at MIT Health says her job allows her to use her entire skill set.
MIT in the media: 2024 in review
MIT community members made headlines with key research advances and their efforts to tackle pressing challenges.
Lara Ozkan named 2025 Marshall Scholar
The MIT senior will pursue graduate studies in the UK at Cambridge University and Imperial College London.
Startup gives surgeons a real-time view of breast cancer during surgery
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
Implantable microparticles can deliver two cancer therapies at once
The combination of phototherapy and chemotherapy could offer a more effective way to fight aggressive tumors.
AI model identifies certain breast tumor stages likely to progress to invasive cancer
The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
Eleven from MIT awarded 2024 Fulbright fellowships
The Fulbright US Student Program funds research, study, and teaching opportunities abroad.
Unlocking mRNA’s cancer-fighting potential
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.